Active human TGF beta 2 full length protein
| Name | Active human TGF beta 2 full length protein |
|---|---|
| Supplier | Abcam |
| Catalog | ab84070 |
| Category | Protein |
| Prices | $110.00, $315.00 |
| Sizes | 2 µg, 10 µg |
| Applications | FA SDS-PAGE WB |
| Species Reactivities | Human |
| Nature | Recombinant |
| Source | HEK 293 cells |
| Purity | > 95 % by SDS-PAGE. Purity is greater than 98% by SDS-PAGE gel and HPLC analyses. Endotoxin level is less than 0.1 ng per µg (1EU/µg). |
| Bioactivity | Biological Activity : Determined by its ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells. The ED 50 was found to be = 0.2 ng/ml, corresponding to a specific activity of = 5 x 10 6 units/mg. |
| Endotoxin | < 0.100 Eu/µg |
| SwissProt/Accession | P61812 |
| Gene | TGFB2 |
| Sequence | ALDAAYCFRN VQDNCCLRPL YIDFKRDLGW KWIHEPKGYN ANFCAGACPY LWSSDTQHSR VLSLYNTINP EASASPCCVS QDLEPLTILY YIGKTPKIEQ LSNMIVKSCK CS |
| Supplier Page | Shop |
Product images
Anti-TGF beta 2 antibody ( ab66045 ) at 1 µg/ml + Active human TGF beta 2 full length protein (ab84070) at 0.1 µg Secondary Goat Anti-Rabbit IgG H&L (HRP) preadsorbed ( ab97080 ) at 1/5000 dilution developed using the ECL technique Performed under reducing conditions. Exposure time : 1 minute
Product References
GARP (LRRC32) is essential for the surface expression of latent TGF-beta on - GARP (LRRC32) is essential for the surface expression of latent TGF-beta on
Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, Shevach EM. Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13445-50. doi:
Chronic NOS inhibition actuates endothelial-mesenchymal transformation. - Chronic NOS inhibition actuates endothelial-mesenchymal transformation.
O'Riordan E, Mendelev N, Patschan S, Patschan D, Eskander J, Cohen-Gould L, Chander P, Goligorsky MS. Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H285-94. Epub 2006 Sep 8.